Tetsuyuki Maruyama
Voorzitter bij Protekt Therapeutics Ltd.
Profiel
Tetsuyuki Maruyama currently works at ProteKt Therapeutics Ltd., as Chairman and FutuRx Ltd., as Scientific Advisor.
Dr. Maruyama received his graduate degree from Stanford University.
Actieve functies van Tetsuyuki Maruyama
| Bedrijven | Functie | Begin |
|---|---|---|
Protekt Therapeutics Ltd.
 Protekt Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Protekt Therapeutics Ltd. operates as a biopharmaceutical company. The firm develop a drug for enhancing the long-term memory of those suffering from mild cognitive impairment. The company is headquartered in Ness Ziona, Israel. | Voorzitter | - |
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Consultant / Adviseur | - |
Opleiding van Tetsuyuki Maruyama
| Stanford University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Protekt Therapeutics Ltd.
Protekt Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Protekt Therapeutics Ltd. operates as a biopharmaceutical company. The firm develop a drug for enhancing the long-term memory of those suffering from mild cognitive impairment. The company is headquartered in Ness Ziona, Israel. | Health Technology |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Finance |
